Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Neoplasm Metastasis

morpholinoanthracycline mx2 has been researched along with Neoplasm Metastasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basser, RL; Cebon, J; Clarke, K; Geldard, H; Green, MD; Hill, JS; Kaye, AH; Maher, DW; Morgan, DJ; Park, SJ; Stylli, SS1
Abe, O; Adachi, I; Enomoto, K; Kajiwara, T; Katsumata, N; Kusama, M; Ogawa, M; Tominaga, T; Watanabe, T; Yamada, Y1

Trials

2 trial(s) available for morpholinoanthracycline mx2 and Neoplasm Metastasis

ArticleYear
Pharmacokinetics and pharmacodynamics of MX2 hydrochloride in patients with advanced malignant disease.
    Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:3

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Area Under Curve; Carubicin; Doxorubicin; Female; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neutropenia; Neutrophils; Safety

1997
Phase II study of KRN8602, 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin hydrochloride, MX2 x HCl in patients with metastatic breast cancer.
    Cancer chemotherapy and pharmacology, 1999, Volume: 43, Issue:6

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Metastasis

1999